Veru's drug lessens loss of lean mass in pa­tients tak­ing We­govy

Veru says its mus­cle-main­tain­ing drug pre­served more lean mass in old­er pa­tients tak­ing a GLP-1, but skit­tish in­vestors didn’t cel­e­brate.

The Mi­a­mi biotech on Mon­day …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER